HKEX Biotech Summit 2018
** Watch all the highlights from the HKEX Biotech Conference 2018
Hong Kong Exchanges and Clearing Limited (HKEX) proudly presents the inaugural HKEX Biotech Summit 2018, an industry conference dedicated to industry professionals to network, exchange insights and experience, and work together to promote the biotech funding ecosystem in Hong Kong.
HKEX has published a public consultation paper seeking public feedback on the proposed new rules to accommodate the listings of companies from emerging and innovative sectors, with a new chapter focusing on the listing of pre-revenue biotech issuers. The proposed new chapter will widen market access for these companies to create a more vibrant marketplace in Hong Kong. For more information, please refer to the link here.
Summit highlights include:
- Discussions around the newly proposed pre-revenue chapter and its impact on the biotech and life sciences industries
- Discover the latest developments in the biotech ecosystem and industry trends both globally and in China
- Connect with senior executives at biotech companies, the investment community, as well as investment banks, accounting and other marketing practitioners in the biotech funding ecosystem.
| Event Details: By Invitation Only |
| Date |
22 March 2018 (Thursday) |
|
Location
|
HKEX Connect Hall
1/F, One and Two Exchange Square, Central, Hong Kong
|
Language
|
English and Mandarin (simultaneous translation available) |
Dress Code
|
Business Attire |
| Tentative Programme |
| Time |
Topic |
| 08:30 |
Guest Registration |
|
09:00
|
Welcome Address
Chung Kong CHOW, Chairman, HKEX Group
|
|
09:05
|
Opening Remarks
Paul CHAN, Financial Secretary, Government of the Hong Kong Special Administrative Region
|
|
09:15
|
Remarks
Carlson TONG, Chairman, Securities and Futures Commission
|
|
09:20
|
Remarks
Ashley ALDER, Chief Executive Officer, Securities and Futures Commission
|
| 09:25 |
Keynote
Charles LI, Chief Executive, HKEX Group
|
|
10:00
|
Keynote: Global Biotech Landscape and Trends
James GREENWOOD, President and CEO, Biotechnology Innovation Organization
|
| 10:30 |
Coffee Break |
|
10:50
|
Keynote: Refining Evaluation Criteria and Accelerating Pharmaceutical Approval
Ruyi HE, Chief Scientist, China Food and Drug Administration Center for Drug Evaluation |
|
11:25
|
Keynote: Development of the Mainland Biotech Industry: Looking into the Future
Ruilin SONG, Executive President, China Pharmaceutical Innovation and Research Development Association (PhIRDA)
|
| 12:00 |
Networking Lunch |
|
13:30
|
Panel 1: Has the East Caught Up to the West in Biotech Development?
Hosted by BayHelix Group (BayHelix)
Moderator: Wenseng PAN, Board Director, BayHelix; Partner, Sidley Austin
Panelists:
- Jun BAO, Board Director, BayHelix; Senior Vice President and Chief Business Officer, acting CFO, Shenogen Pharma Group
- Bin LI, Partner and Managing Director, Ally Bridge Group; CEO and CIO, Ally Bridge LB Healthcare Fund
- Marietta WU, Managing Director, Quan Venture Fund; Co-Founder, Zai Lab
- Dan ZHANG, Chairman, Fountain Medical Group
|
|
14:20
|
Panel 2: Does China Have What it Takes to Lead the World in terms of Innovation?
Hosted by PhIRDA
Moderator: Lawrence TIAN, Founding Partner, YuanMing Capital
Panelists:
- Daniel LEE, Head of Biomedical Technology Cluster, Hong Kong Science and Technology Parks
- Ting XU, President and CEO, Alphamab
- Dajun YANG, Co-Founder, Chairman and CEO, Ascentage Pharma
- Michael YU, Chairman and CEO, Innovent Biologics
|
| 15:10 |
Coffee Break |
|
15:30
|
Panel 3: When is it the Right Time to Capitalize on PE Investments or Go Public?
Hosted by China HealthCare Investment 50 Forum
Moderator: Feng DENG, Founding Managing Director, Northern Light Venture Capital
Panelists:
- Daqing CAI, Managing Director, Legend Capital
- Kevin CHEN, Founding Partner, Biotrack Capital
- Yusheng HAN, CEO, Burning Rock Dx
- Frank JIANG, Managing Partner, CStone Pharmaceuticals
- John ZHU, Partner, 6 Dimensions Capital
|
|
16:20
|
Panel 4: A CEO Dialogue
Hosted by Charles LI, Chief Executive, HKEX Group
Panelists:
- Chris CHEN, CEO, WuXi Biologics
- Jun WANG, Founder and CEO, iCarbonX; Chairman, AOBiome
- Xiaodong WANG, Founder and Chairman, BeiGene
|
| 17:15 |
Closing Remarks |
| 17:30 |
Networking Cocktail |
Note: The Programme is subject to further changes without prior notice. Please check back again for latest information.
For enquiries, please contact Organising Committee of the HKEX Biotech Summit 2018 at biosummit@hkex.com.hk.
